We report net peptide content, not just purity — so the milligrams you dose aren't padded with water and counter-ion. RP-HPLC purity and ESI-MS identity, on a lot-numbered COA.
Net peptide content, not just purity — RP-HPLC + ESI-MS, lot-numbered COA.
Net peptide content on every lot's COA.
Reading a Peptide HPLC Trace — A 5-Minute Field Guide for Bench Scientists. Read our briefing →
Reading a peptide HPLC trace — a field guide. Read →
On reading HPLC traces. Read →
Mitochondrial-derived peptide
Lyochem buyer fit
This Lyochem page is intentionally written for research labs, core facilities, and method-development teams qualifying MOTS-c (Human) as a reference-grade lot. It is not the pharmacy procurement owner for this SKU; the page should win differentiated searches around sequence verification, assay suitability, lot continuity, and data-packet depth.
Overview
MOTS-c is a mitochondrial-derived peptide (MDP) of 16 residues, sequence MRWQEMGYIFYPRKLR, its coding sequence lies inside the human mitochondrial genome, specifically the 12S ribosomal RNA region. It ranks among the best-characterized examples of the MDP class, a set of small peptides translated from short open reading frames embedded in mitochondrial rRNA. Signaling proceeds through AMPK-pathway activation, and the peptide has drawn research attention for effects spanning insulin sensitivity, glucose metabolism, exercise capacity, weight regulation, and age-associated mitochondrial decline, placing it among the more translationally interesting entries in mitochondrial biology. Lyochem supplies MOTS-c acetate as a lyophilized reference standard at ≥99.0% HPLC purity. Each lot's release packet reports integrated-peak HPLC alongside ESI-MS checked against the ~2174.6 Da theoretical mass, plus counter-ion and water-content figures, with LC-MS/MS sequence verification available on request. Because plasma persistence is brief, on the order of minutes to a few hours, the compound suits acute mitochondrial-signaling experiments; protocols aiming at sustained exposure generally rely on repeated dosing or sustained-release formats. Four fills from 10 to 40 mg accommodate routine aliquoting through larger dispensing scales. Research use only.
Applications & buyer fit
Mitochondrial-targeted peptides — MOTS-c, SS-31 (Elamipretide) — and the mitochondrial-targeting small-molecule reagents (NAD+, AICAR, 5-Amino-1MQ, SLU-PP-332) ship to research labs studying OXPHOS, ROS biology, sirtuin-mediated deacetylation, and mitochondrial dysfunction in disease models. The lipophilic / cationic character that drives mitochondrial accumulation also makes some peptides oxidation-prone in solution; working stocks should be prepared fresh or held at −80 °C when the workflow permits.
Biotech R&D Groups
Preclinical biotech and pharmaceutical discovery teams sourcing characterized peptides for receptor-pharmacology, screening, and method-development campaigns.
Academic Laboratories
Universities, medical schools, and government research institutes qualifying a reference standard for a method-development or in vivo workflow.
Every release ships with its own batch-specific CoA — identity, purity, and the analytical scope agreed at quote stage, tied to the exact lot you receive.
Review a representative batch CoA before you order, so you can confirm the packet matches what your method or sponsor audit needs.
Supplied strictly as a research reagent to research institutions — not a finished dosage form and not for human administration. Buyer qualification runs at the inquiry stage.
Specifications
Documentation available on request
Regulatory note
Lyochem supplies MOTS-c strictly for Research Use Only; buyers are responsible for verifying ingredient eligibility in their destination market.
Selected literature
Frequently asked questions
MOTS-c is a short peptide translated from a mitochondrial small open reading frame, so it is well within routine synthesis and characterization range. RP-HPLC establishes chromatographic purity as a single dominant peak, and ESI-MS confirms the intact mass and therefore the intended sequence. An analyst treating the vial as a defined reference material should expect both a mass-spec identity confirmation and an HPLC purity value on the specific batch, so that any downstream reading of AMPK-pathway or metabolic-signaling activity is anchored to verified material rather than an assumed identity.
The two are distinct sequences of different composition and length, so intact-mass measurement by ESI-MS is the fastest discriminator, and RP-HPLC gives independent separation at differing retention times. SS-31 additionally carries the aromatic-cationic residue pattern that drives its inner-membrane accumulation, giving it a chromatographic and mass signature unlike the endogenously encoded MOTS-c. When both are handled in the same lab, confirming each batch against its own mass and reference-standard retention prevents a mix-up between a nucleus-directed signaling peptide and a cardiolipin-protective one before either enters an assay.
Related peptides